BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31011918)

  • 1. High-grade glioneuronal tumor with an ARHGEF2-NTRK1 fusion gene.
    Kurozumi K; Nakano Y; Ishida J; Tanaka T; Doi M; Hirato J; Yoshida A; Washio K; Shimada A; Kohno T; Ichimura K; Yanai H; Date I
    Brain Tumor Pathol; 2019 Jul; 36(3):121-128. PubMed ID: 31011918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases.
    Appay R; Pages M; Colin C; Jones DTW; Varlet P; Figarella-Branger D
    Acta Neuropathol Commun; 2020 Jun; 8(1):95. PubMed ID: 32605662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.
    Deng MY; Sill M; Chiang J; Schittenhelm J; Ebinger M; Schuhmann MU; Monoranu CM; Milde T; Wittmann A; Hartmann C; Sommer C; Paulus W; Gärtner J; Brück W; Rüdiger T; Leipold A; Jaunmuktane Z; Brandner S; Giangaspero F; Nozza P; Mora J; Morales la Madrid A; Cruz Martinez O; Hansford JR; Pietsch T; Tietze A; Hernáiz-Driever P; Stoler I; Capper D; Korshunov A; Ellison DW; von Deimling A; Pfister SM; Sahm F; Jones DTW
    Acta Neuropathol; 2018 Aug; 136(2):239-253. PubMed ID: 29766299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse leptomeningeal glioneuronal tumor without KIAA1549-BRAF fusion and 1p detection: a case report and review of literature.
    Cheng W; He L; Zhu J; Fan X
    Childs Nerv Syst; 2022 Feb; 38(2):279-285. PubMed ID: 34977973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual radiological and histological presentation of a diffuse leptomeningeal glioneuronal tumor (DLGNT) in a 13-year-old girl.
    Tiwari N; Tamrazi B; Robison N; Krieger M; Ji J; Tian D
    Childs Nerv Syst; 2019 Sep; 35(9):1609-1614. PubMed ID: 30770994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric diffuse leptomeningeal tumor with glial and neuronal differentiation harbouring chromosome 1p/19q co-deletion and H3.3 K27M mutation: unusual molecular profile and its therapeutic implications.
    Nambirajan A; Suri V; Kedia S; Goyal K; Malgulwar PB; Khanna G; Panda PK; Gulati S; Garg A; Sharma MC
    Brain Tumor Pathol; 2018 Jul; 35(3):186-191. PubMed ID: 30030640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging glioneuronal and neuronal tumors: case-based review.
    Lim SD; Kim SI; Park JW; Won JK; Kim SK; Phi JH; Chung CK; Choi SH; Yun H; Park SH
    Brain Tumor Pathol; 2022 Apr; 39(2):65-78. PubMed ID: 35048219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse leptomeningeal glioneuronal tumor in a Chinese adult: a novel case report and review of literature.
    Xu H; Chen F; Zhu H; Luo L; Zhang R
    Acta Neurol Belg; 2020 Apr; 120(2):247-256. PubMed ID: 31875302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas.
    Yamauchi T; Ohno M; Matsushita Y; Takahashi M; Miyakita Y; Kitagawa Y; Kondo E; Tsushita N; Satomi K; Yoshida A; Ichimura K; Narita Y
    Brain Tumor Pathol; 2018 Jul; 35(3):148-158. PubMed ID: 29922974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual high-grade features in pediatric diffuse leptomeningeal glioneuronal tumor: comparison with a typical low-grade example.
    Schwetye KE; Kansagra AP; McEachern J; Schmidt RE; Gauvain K; Dahiya S
    Hum Pathol; 2017 Dec; 70():105-112. PubMed ID: 28652147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
    Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
    Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic changes of diffuse leptomeningeal glioneuronal tumor with polar spongioblastoma pattern.
    Yamasaki T; Sakai N; Shinmura K; Kawaji H; Koizumi S; Samashima T; Namba H
    Brain Tumor Pathol; 2018 Oct; 35(4):209-216. PubMed ID: 30051174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
    Richardson TE; Tang K; Vasudevaraja V; Serrano J; William CM; Mirchia K; Pierson CR; Leonard JR; AbdelBaki MS; Schieffer KM; Cottrell CE; Tovar-Spinoza Z; Comito MA; Boué DR; Jour G; Snuderl M
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1089-1099. PubMed ID: 31626289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.
    Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW
    Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.
    Dodgshun AJ; SantaCruz N; Hwang J; Ramkissoon SH; Malkin H; Bergthold G; Manley P; Chi S; MacGregor D; Goumnerova L; Sullivan M; Ligon K; Beroukhim R; Herrington B; Kieran MW; Hansford JR; Bandopadhayay P
    J Neurooncol; 2016 Jun; 128(2):293-302. PubMed ID: 26994902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.
    Li YX; Shi Z; Aibaidula A; Chen H; Tang Q; Li KK; Chung NY; Chan DT; Poon WS; Mao Y; Wu J; Zhou L; Chan AK; Ng HK
    Oncotarget; 2016 Oct; 7(40):64615-64630. PubMed ID: 27556304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].
    Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M
    Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
    Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::MET fusion.
    Chapman N; Greenwald J; Suddock J; Xu D; Markowitz A; Humphrey M; Cotter JA; Krieger MD; Hawes D; Ji J
    Acta Neuropathol Commun; 2024 Apr; 12(1):63. PubMed ID: 38650040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.